Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-978,310
Closed -$3.07M 80
2024
Q4
$3.07M Hold
978,310
0.05% 65
2024
Q3
$4.82M Hold
978,310
0.07% 59
2024
Q2
$4.31M Hold
978,310
0.07% 57
2024
Q1
$6.6M Hold
978,310
0.1% 56
2023
Q4
$7.3M Hold
978,310
0.11% 54
2023
Q3
$9.95M Hold
978,310
0.21% 47
2023
Q2
$20.4M Buy
+978,310
New +$20M 0.39% 37

Other funds holding SLRN

RTW Investments's SLRN Position: Q1 2025 in Review

RTW Investments sold out of ACELYRIN (SLRN) in Q1 2025, closing a stake of 978,310 shares — an estimated $3.07M sold.

RTW Investments first reported a position in SLRN in Q2 2023 and held it in 7 quarters. The position peaked at $20.4M in Q2 2023. 105 funds tracked by Wall St. Rank hold SLRN as of Q1 2025.

  • RTW Investments reported no remaining ACELYRIN position as of Q1 2025 after selling out during the quarter.
  • RTW Investments sold 978,310 ACELYRIN shares in Q1 2025, an estimated $3.07M.
  • RTW Investments first reported a position in ACELYRIN in Q2 2023 and held it in 7 quarters.
  • RTW Investments's ACELYRIN position peaked at $20.4M in Q2 2023.
  • 105 funds tracked by Wall St. Rank held ACELYRIN as of Q1 2025.

Based on RTW Investments's 13F filing for Q1 2025, filed 15 May 2025.